Cynthia W. Hu - 24 Mar 2022 Form 4 Insider Report for Mind Medicine (MindMed) Inc. (MNMD)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
28 Mar 2022, 20:30:10 UTC
Prior SEC filing
10 Jan 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Robert Barrow, Attorney-in-Fact

Key filing fact

Cynthia W. Hu filed Form 4 for Mind Medicine (MindMed) Inc. (MNMD) on 28 Mar 2022.

Key facts

  • This page summarizes Cynthia W. Hu's Form 4 filing for Mind Medicine (MindMed) Inc. (MNMD).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 28 Mar 2022, 20:30.

Change

  • Previous filing in this sequence was filed on 10 Jan 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MNMD transaction

Subordinate Voting Shares

Award

Transaction value
$0
Shares
+1,200,000
Change %
Price
$0.000000
Shares after
1,200,000
Date
24 Mar 2022
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MNMD transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+1,560,000
Change %
Price
$0.000000
Shares after
1,560,000
Date
24 Mar 2022
Ownership
Direct
Underlying class
Subordinate Voting Shares
Underlying amount
1,560,000
Exercise price
$1.18
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. Of these RSUs, 25% shall vest on December 6, 2022, with 1/48th vesting at the end of each month thereafter for the succeeding 36 months, subject, to the Reporting Person providing continuous service to the Issuer on each such vesting date.

Footnote F2

The option grant has an exercise price of $1.48 Canadian Dollars. This represents the exercise price in United States Dollars.

Footnote F3

25% of the shares underlying the option shall vest and become exercisable on December 6, 2022; the remaining shares underlying the option shall vest and become exercisable with 1/48th of the total shares vesting at the end of each month thereafter for the succeeding 36 months, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .